Table 1.
FDA-approved Pharmacologic Agents Studying Ischemia-Reperfusion Injury in Rat Testicular Torsion-Detorsion Models. Arrows (↑ or ↓) indicate the direction of effect of the marker after the intervention is applied. [References are listed in Appendix 1].
| Author | Year | Intervention | Route | Timing of intervention | Duration of ischemia (hours) | Timing of endpoint (after detorsion) | Oxidative Markers | Histology | Apoptosis and Necrosis | Hormonal profile | Fertility potential | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MDA (↓ = lowerMDA = less damage) | SOD (↑ = higher SOD = less damage) | tGSH/GPx/GST (↑ = higher level = less damage) | NO (↓ = lower NO = less damage) | TNF-α (↓ = lower TNF = less damage) | Caspase-3 (↓ = lower level = less damage) | IL-2/IL-6/IL-10 (↓ = lower IL = less damage) | Catalase (↓ =lower level = less damage) | TOS (↓ = lower level = less damage) | TAOS (↑ = higher level = less damage) | XO (↓ = lower XO = less damage) | MPO (↓ = lower MPO = less damage) | Johnsen Score (↑ = higher score = less damage) | Cosentino Score (↓ = lower score = less damage) | STD (↑ = higher score = less damage) | GET (↑ = higher score = less damage) | TUNEL (↓ = lower score = less damage) | Hormones (↑ = higher level = better profile) | Sperm parameters (↑ = higher level = better profile) | |||||||
| Comparative Studies - agent in red had a greater effect | |||||||||||||||||||||||||
| Azizollahi, S | 2011 | Vitamin C versus dopamine, or both | Unclear | Unclear | 4 | Unclear | ↓ | ↑ | ↑ | ||||||||||||||||
| Quintaes, IPP | 2020 | EGF versus decopressive fasciotomy with flap, or both | Subcutaneous | Immediately after detorsion | 4 | 21 days | ↑ | ||||||||||||||||||
| Keseroglu, BB | 2019 | Ibuprofen versus metamizole versus paracetamol | Oral | 60 mins after torsion | 4 | 8 days | ↓ | ↓ | ↓ | ↓ | |||||||||||||||
| Semercioz, A | 2017 | Melatonin* or zinc, or both | Intra-peritoneal | 3 weeks post-op | 1 | 1 hour | ↓ | ↑ | ↑ | ↑ | |||||||||||||||
| Sekmenli, T | 2017 | Colchicine versus melatonin | peritoneal or oral | 15 mins prior to detorsion | 6 | Unclear | ↓ | ↓ | ↓ | ↑ | ↑ | ↓ | |||||||||||||
| Yurtcu, M | 2009 | Melatonin versus methylprednisolone | peritoneal (melatonin) | detorsion, 1 dose versus 7 doses | 6 | 3 months | ↑ | ||||||||||||||||||
| Isikdemir, F | 2014 | Zileuton versus montelukast | Intra-peritoneal | 30 mins prior to detorsion | 1 | 3 hours | ↓ | ↑ | |||||||||||||||||
| Salmasi, AH | 2005 | Morphine versus naltrexone, or both | Intravenous | Immediately prior to detorsion | 1 | 4 hours | ↓ | ↑ | ↑ | ↓ | ↑ | ||||||||||||||
| Yuvanc, E | 2018 | Nebivolol versus Pheniramine maleate | Intra-peritoneal | 60 mins prior to detorsion | 2 | 4 hours | ↓ | ↑ | ↑ | ||||||||||||||||
| Kostakis, ID | 2017 | Sildenafil versus erythropoeitin (low versus high dose) | Intra-peritoneal | 60 mins after torsion | 1.5 | 24 hours | ↓ | ↑ | ↓ | ||||||||||||||||
| Dejban, P | 2019 | Sumatriptan versus GR-127935 (selective antagonist of 5HT1B/1D-R) | Intra-peritoneal | Unclear | 1 | 7 days | ↑ | ↓ | ↑ | ↓ | |||||||||||||||
| Ameli, M | 2018 | Tadalafil versus verapamil, or both | Unclear | 30 mins prior to detorsion | Unclear | 24 hours | ↓ | ↑ | ↑ | ↑ | ↑ | ↑ | ↑ | ||||||||||||
| Yildirim, C | 2018 | Tadalafil versus darbopoetin, or both | Intra-peritoneal | 30 mins after torsion | 2 | 30 mins | ↓ | ↑ | ↓ | ||||||||||||||||
| Karagoz, MA | 2018 | Papaverine versus alprostadil | spermatic cord | Immediately after detorsion | 4 | 14 days | ↑ | ↓ | |||||||||||||||||
| Mertoglu, C | 2010 | Methylprednisolone versus heparin | Intra-peritoneal | 30 mins prior to detorsion | 2 | 2 hours | ↓ | ↑ | ↑ | ↓ | ↓ | ↑ | |||||||||||||
| Ozmerdiven, G | 2017 | Tadalafil versus L-arginine, or both | Intra-peritoneal | 30 mins prior to detorsion | 3 | 4 hours | ↑ | ↑ | |||||||||||||||||
| Single-Agent Studies | |||||||||||||||||||||||||
| Un, H | 2015 | Aliskiren | Oral | 30 mins prior to torsion | 2 | 2 hours | ↓ | ↑ | ↑ | ↓ | ↓ | ↑ | |||||||||||||
| Dogan, C | 2016 | Amlodipine | Intra peritoneal | 30 mins prior to torsion | 2 | 2 hours | ↓ | ↑ | ↑ | ↓ | ↑ | ||||||||||||||
| Hirik, E | 2018 | Anakinra | Intra-peritoneal | Unclear | 4 | 4 hours | ↓ | ↑ | ↓ | ↓ | |||||||||||||||
| Gozukara, KH | 2020 | Colchicine | “Infusion” | 30 minutes prior to detorsion | 3 | Unclear | ↓ | ↑ | ↑ | ↓ | ↑ | ↑ | ↑ | ↓ | |||||||||||
| Yazdani, I | 2019 | Cyclosporine | Intra-venous | 30 and 90 mins after torsion | 1 | hours Histology at 24 | ↓ | ↑ | ↑ | ↓ | ↓ | ↓ | ↑ | ↓ | ↑ | ||||||||||
| Dejban.P | 2019 | Dapsone | Intra-peritoneal | Unclear | 1 | 7 days | ↑ | ↓ | ↑ | ||||||||||||||||
| Hand,V | 2010 | Dexmedetomidine | Intra-peritoneal | 30 mins after torsion | 1 | 4 hours | ↓ | ↓ | ↑ | ↓ | |||||||||||||||
| Uguralp, S | 2004 | EGF on gelatin film | Testicular wrap | Immediately after detorsion | 4 | 7 and 21 days | ↓ | ↑ | ↑ | ↑ | |||||||||||||||
| Rashed, FK | 2013 | Erythropoietin | Intra-venous | Immediately after torsion | 2 | 7 days | ↑ | ↓ | |||||||||||||||||
| Bozkurt, M | 2020 | Hydrogen sulfide | Intra-peritoneal | 30 mins prior to detorsion | 2 | 4 hours | ↓ | ↑ | ↑ | ↓ | ↓ | ↑ | ↓ | ||||||||||||
| Dokmeci, D | 2007 | Ibuprofen | Oral | 40 mins prior to detorsion | 5 | 5 hours versus 7 days | ↓ | ↓ | ↑ | ↑ | |||||||||||||||
| Kazemi-Darabadi, S | 2019 | L-carnitine + betamethasone | Intra-peritoneal | Immediately after torsion | 6 | 12 hours | ↑ | ↑ | ↑ | ↑ | |||||||||||||||
| Kurt, O | 2016 | Mannitol | “Infusion” | Immediately after torsion | 3 | 2 hours | ↓ | ↑ | ↑ | ↓ | ↓ | ↑ | ↑ | ↓ | |||||||||||
| Yurtcu, M | 2008 | Melatonin* | Intra-peritoneal | 15 mins prior to detorsion | 6 | 7 days | ↓ | ↑ | ↑ | ||||||||||||||||
| Ghasemnejad-Berenji, M | 2018 | Metformin | Unclear | Unclear | 1 | hours Sperm | ↓ | ↑ | ↑ | ↓ | ↑ | ↓ | ↑ | ||||||||||||
| Yousefi-Manesh, H | 2019 | Modafinil | Intra-peritoneal | 7 days post-op | 1 | 7 days | ↓ | ↓ | ↓ | ↑ | ↑ | ||||||||||||||
| Acer-Demir, T | 2019 | N-acetylcysteine | Intra-tunica vaginalis | 30 minutes prior to detorsion | 3 | 30 days | ↑ | ↓ | ↑ | ↑ | |||||||||||||||
| Kazaz, 10 | 2019 | N-acetylcysteine | Intra-peritoneal | 30 minutes prior to detorsion | 4 | 2 hours | ↑ | ↓ | |||||||||||||||||
| Mestrovic, J | 2014 | Nifedipine | Intra-peritoneal | 30 mins prior to detorsion | 3 | 3 hours | ↓ | ↑ | ↑ | ↓ | |||||||||||||||
| Lee, JW | 2019 | Nitrous versus nitrous + C-PTIO (NO Scavenger) | Intra-venous | Unclear | 5 | 24 hours | ↓ | ↑ | ↓ | ↑ | ↑ | ↑ | |||||||||||||
| Ghasemnezhad, R | 2015 | Oxytocin | Intra-peritoneal | Immediately after detorsion | 2 | 3 hours | ↑ | ↑ | ↓ | ↑ | |||||||||||||||
| Firat, F | 2018 | Oxytocin | Intra-peritoneal | 30 mins prior to detorsion | 3 | 3 hours | ↓ | ↑ | ↑ | ↓ | ↑ | ||||||||||||||
| Savas, C | 2002 | Pentoxifylline | Intra-peritoneal | 15 mins prior to torsion | 0.5 | 30 mins | ↓ | ↓ | |||||||||||||||||
| Mahmoud, NM | 2019 | Pioglitazone | Intra-peritoneal | 30 minutes prior to detorsion | 4 | 4 hours | ↓ | ↑ | ↑ | ↓ | ↓ | ↓ | ↓ | ↑ | ↓ | ||||||||||
| Wei, SM | 2017 | Probucol | Intra-peritoneal | Immediately after detorsion | 2 | hours Histology at 3 | ↓ | ↓ | ↑ | ||||||||||||||||
| Urt Filho, A | 2012 | Propofol | Intra-peritoneal | 45 mins after torsion | 1 | 90 days | ↑ | ||||||||||||||||||
| Unsal, A | 2004 | Propofol | Intra-peritoneal | 30 mins prior to detorsion | 2 | Unclear | ↓ | ↑ | ↓ | ↓ | ↑ | ||||||||||||||
| Zheng, N | 2018 | Rosiglitazone | Unclear | Unclear | 2 | 24 hours | ↓ | ↓ | ↓ | ↓ | ↓ | ||||||||||||||
| Kara, O | 2016 | Selenium | Unclear | Unclear | 3 | Unclear | ↓ | ↑ | ↑ | ↑ | ↑ | ↑ | |||||||||||||
| Jafari, A | 2020 | Topiramate | Unclear | 30 mins prior to detorsion | 1 | 5 hours | ↓ | ↑ | ↑ | ↓ | ↑ | ||||||||||||||
| Erol, B | 2009 | Vardenafil | Intra-peritoneal | 30 mins after torsion | 1 | 4 hours | ↓ | ↓ | ↓ | ↑ | ↓ | ||||||||||||||
| Tunckiran, A | 2005 | VEGF | Intra-testicular | Pre-torsion | 2 | 2 months | ↓ | ↑ | ↑ | ↑ | |||||||||||||||
Abbreviations are as follows: malonedialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GPx), total glutathione (tGSH), glutathione S-transferase (GST), nitric oxide (NO), tumor necrosis factor-α (TNF-α), TOS (total oxidant status), TAOS (total anti-oxidant status), myeloperoxidase (MPO), transforming growth factor-beta (TGF-beta), xanthine oxidase (XO), STD (seminiferous tubule diameter), GET (germinal epithelium thickness), and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL).
on formulary at hospitals but not strictly FDA-approved